About Sia Anagnostou

Sia Anagnostou, Venture Partner, also serves as Head of Corporate Development at Immunomic Therapeutics. In this role, she is responsible for several core areas including alliance development, product pipeline, external communications, and government relations.In collaboration with R&D, she has been responsible for the Company’s overall corporate strategy and portfolio started in immune-oncology. She has sourced, transacted and advanced in-licensing opportunities. Further, she has raised awareness about Immunomic with important stakeholders in the science, government and investment communities through directing ITI branding initiatives, messaging, external communications and government relations. Mrs. Anagnostou previously founded and sold her company in the retail and international import space, spent two years in corporate development at Theranostics Health, where she focused on cancer proteomic molecular diagnostics, and spent two years at a consultancy starting and raising seed capital for companies. She earned her executive M.B.A. from Duke University, her M.S. in Molecular Biology from Georgetown University and her B.S. in Foreign Service from Georgetown University.